
A | The Filmfare OTT Awards 2025 was a spectacular night, celebrating the power-packed performances and stellar content that shined on streaming platforms over the past year. While many stars took home the Black Lady, it was a beautiful moment of genuine camaraderie between Sanya Malhotra and Alia Bhatt, that truly stole the show and captured the hearts of everyone watching. Sanya Malhotra was the winner in the category of Best Actor, Web Original Film (Female), for her compelling and memorable performance in the film Mrs. As Sanya walked up to the stage, the camera caught a glimpse of Alia Bhatt, who was seen cheering and clapping with enthusiasm, a reaction that was very wholesome. View this post on Instagram A post shared by Filmfare (@filmfare) The win for Mrs. was certainly well-deserved. In the film, Sanya took on the challenging role of a homemaker named Richa, who begins a journey of self-discovery and reclaiming her identity within the confines of her marriage. Her performance was both sensitive and powerful. Sanya nailed the quiet dignity and underlying frustration of a woman often overlooked, making Richa’s eventual awakening feel authentic and deeply moving for the audience. The critical praise for her performance highlighted her exceptional performance, making her the top choice for the award. During her acceptance speech, Sanya was visibly emotional, expressing her gratitude to the makers of Mrs. and her family. Even as she spoke, the support from her industry peers was evident. The moment she finished her winning speech, it was Alia Bhatt’s loud cheer that cut through the applause, offering an extra dose of encouragement that radiated warmth and respect across the venue. This small but supportive gesture of celebration from one star to another was a genuine highlight, reminding us of the bond shared by artists in the industry. On the work front, Sanya was last seen in the rom-com Sunny Sanskari Ki Tulsi Kumari, alongside Varun Dhawan, Janhvi Kapoor, and Rohit Saraf. Also Read: 15 upcoming Bollywood pairings to watch out for in 2022。

B | 沪深两市半日成交额达5008亿,较上个交易日上午缩量21亿。北向资金方面,沪股通早盘净流入7.99亿,深股通早盘净流入21.13亿。
盘面上,贵金属板块大涨,金贵银业涨停,赤峰黄金创阶段新高。养殖板块震荡走强,天邦食品领涨。汽车整车股盘中异动,亚星客车涨停。此外中药、白酒、油气等板块均有所活跃,但大多数个股均冲高回落。整体上市场热点较为杂乱,无特别强势的主线。
C | 下跌方面,CRO概念股重挫,康龙化成、药石科技跌超10%,凯莱英跌停。
涨幅前五的行业分别是采掘行业3.07%、贵金属2.68%、农牧饲渔2.39%、汽车整车2.24%、酿酒行业1.91%。跌幅前五的行业分别是电力行业-1.85%、风电设备-1.64%、房地产开发-1.44%、光伏设备-1.39%、燃气-1.33%。、9月13日早盘,主力资金净流入有色、农业、银行、白酒等板块,净流出医药、电力、煤炭、光伏等板块。个股净流入方面,西藏矿业、招商银行、贵州茅台获净流入6.91亿元、5.66亿元、5.53亿元。净流出方面,药明康德、粤宏远A、凯莱英遭抛售8.73亿元、3.58亿元、3.26亿元。NO.1 近日,网传北京市管企业收到北京国资委通知,梳理与复星集团的合作情况(不限于持有股票,股权投资,资金出借,工程承包,担保,商贸合作等事项),并研判相关合作风险,形成书面报告。对此,复星集团回应称:我们留意到有网传“北京市国资委通知”。
D | 经向北京国资委问询,获悉这一调研是北京市国资委系统的一项日常信息搜集工作,没有任何针对性,此前他们也对有关企业发过相关调研通知。复星在北京各项业务发展正常。

E | 8月31日公司刚发布半年报,在当前宏观环境复杂多变的背景下,依旧保持稳健和韧劲,各项业务平稳运行。(第一财经)
NO.2 受美国准备签署行政法令,帮助扩大美国生物制造业消息的影响,A股市场的CXO、CDMO概念股大跌。
F | 其中,凯莱英、药明康德跌停,康龙化成、药石科技跌幅超过10%,泰格医药也一度逼近跌停。对此,泰格医药方面表示,从目前公开消息来看,主要针对的是临床前CRO业务,对泰格医药目前业务没有影响,公司不涉及CDMO和生物医药业务。(证券时报)
NO.3 9月13日上午,CXO概念板块大跌,凯莱英跌停,药明康德、九洲药业逼近跌停,康龙化成跌超11%。消息称美国总统拜登准备签署一项行政命令,帮助扩大美国的生物制造业,减少对于中国的依赖。
G | 药明康德人士9月13日上午向记者表示,公司也关注到上述信息,“公司业务和运营一切正常。”(证券时报)NO.4 记者以投资者身份从博腾股份证券部获悉:“目前行政命令还没有更多实施细则,至少短期内没有看到对我们业务有实质性影响,因为医药制造行业不是突然说转就能转,还涉及很多法规。

H | 长期来看,公司肯定会有一些应对措施,因为我们本来就做国际化生意,公司在此之前已经在欧洲布局研发生产基地。”昨日白宫消息,美国总统拜登签署一项行政命令,启动一项国家生物技术和生物制造倡议。

I | 今日国内CXO概念股领跌,博腾股份最大跌幅近9%。(财联社)NO.5 飞常准APP数据显示,9月13日上午,两架C919先后飞往北京首都国际机场,分别于10时51分和11时24分到达。数据显示,两架C919飞机注册号分别为B-001F和B-001J,于9时6分和9时40分从上海浦东国际机场相继起飞。(新京报)康弘药业(SZ002773,股价15.6元,市值143.4亿元)9月13日午间公告称,子公司济生堂生产的舒肝解郁胶囊获批国家中药二级保护品种。美联新材(SZ300586,股价18.27元,市值95.82亿元)9月13日午间发布公告,公司自主研发的“一种以聚乳酸回收废弃料为载体的彩色母粒及其制备方法”取得发明专利证书。金融街(SZ000402,股价5.68元,市值169.8亿元)9月13日午间公告称,公司董事王开国因个人原因辞去公司第九届董事会董事等一切职务,辞职后不在金融街及其控股子公司担任任何职务。

J | 王开国未持有公司股份。

K | 志特新材(SZ300986,股价38.59元,市值63.25亿元)9月13日午间发布公告,向不特定对象发行可转换公司债券申请获得深交所受理。常山北明(SZ000158,股价6.15元,市值98.31亿元)9月13日午间公告称,原棉二分公司厂区土地使用权挂牌出让,该地块竞拍起始价为13.95亿元,增价幅度为100万元/次。由于该地块拍卖价格及搬迁支持资金返还时间不确定,此次公开出让对公司本期及期后利润的影响不确定。每日经济新闻返回搜狐,查看更多责任编辑:
Current article:http://www.lichuorenrenyitankanmeimu.cfd/naqcu/20260826/1396.docx
Published on:16:27:50